Showing results (441-450 of 976) with videos related to
Sort By:
Pageof 98
Obstetrics and Gynecology|September 2, 2006
Evaluation of polymerase chain reaction for group B streptococcus detection using an improved culture methodKristin L Atkins, Robyn M Atkinson, Anthony Shanks, et al.Immunology and Cell Biology|August 1, 1989
Localization of a 23,000 MW antigen of Cryptosporidium by immunoelectron microscopyR Lumb, P S Smith, R Davies, et al.Infectious Diseases of Poverty|February 27, 2016
Moving interdisciplinary science forward: integrating participatory modelling with mathematical modelling of zoonotic disease in AfricaCatherine Grant, Giovanni Lo Iacono, Vupenyu Dzingirai, et al.Immunogenetics|October 20, 2012
Influence of Tyrphostin AG490 on the expression of diabetes-associated markers in human adipocytesAbdoreza Davoodi-Semiromi, C H Wasserfall, A Hassanzadeh, et al.Lancet (London, England)|January 19, 1985
Precursor prothrombin status in patients receiving anticonvulsant drugsV A Davies, A D Rothberg, A C Argent, et al.Australian Veterinary Journal|January 20, 2012
Haemochromatosis in a Brazilian tapir (Tapirus terrestris) in an Australian zooA Peters, S R Raidal, A H Blake, et al.Journal of Vector Ecology : Journal of the Society for Vector Ecology|May 28, 2016
Hyalomma ticks on northward migrating birds in southern Spain: Implications for the risk of entry of Crimean-Congo haemorrhagic fever virus to Great BritainMarion E England, Paul Phipps, Jolyon M Medlock, et al.The British Journal of Surgery|June 1, 1984
A frequency-duration index (FDI) for the evaluation of ambulatory recordings of gastro-oesophageal refluxF J Branicki, D F Evans, J A Jones, et al.British Journal of Pharmacology|April 29, 2014
Characterization of the heterozygous glucokinase knockout mouse as a translational disease model for glucose control in type 2 diabetesD J Baker, A M Atkinson, G P Wilkinson, et al.Pain Medicine (Malden, Mass.)|December 25, 2009
The Brief Pain Inventory and its "pain at its worst in the last 24 hours" item: clinical trial endpoint considerationsThomas M Atkinson, Tito R Mendoza, Laura Sit, et al.Pageof 98